Brain Tumor Res Treat.  2019 Oct;7(2):141-146. 10.14791/btrt.2019.7.e32.

Found at Old Age and Continuously Growing WHO Grade II Fourth Ventricle Ependymoma: A Case Report

Affiliations
  • 1Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Pathology, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 3Department of Radiology, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 4Department of Cancer Control, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. nsghs@ncc.re.kr

Abstract

A 74-year-old woman presented with a month-long nausea and vomiting, then she could not take a meal. She had found an asymptomatic 4th ventricular mass 6 year ago as a preoperative work-up for ovarian cancer. And during the yearly follow-up, the mass had grown continuously over 6 years, and caused symptoms in the seventh year. MRI revealed a large ovoid extra-axial mass in the fourth ventricle compressing adjacent medulla and cerebellum. Surgery achieved near total resection since the tumor tightly adhered to the brain stem of 4th ventricle floor. The histological diagnosis was ependymoma (WHO grade II). She transferred rehabilitation facility for mild gait disturbance, hoarseness and swallowing difficulty. Fourth ventricle ependymoma in the elderly is extremely rare and the growth rate has not been reported. Here, we present a rare care of 4th ventricle ependymoma found asymptomatic at elderly but continuously grow to cause local pressure symptoms.

Keyword

Ependymoma; Grade II; Fourth ventricle; Elderly

MeSH Terms

Aged
Brain Stem
Cerebellum
Deglutition
Diagnosis
Ependymoma*
Female
Follow-Up Studies
Fourth Ventricle*
Gait
Hoarseness
Humans
Magnetic Resonance Imaging
Meals
Nausea
Ovarian Neoplasms
Rehabilitation
Vomiting

Figure

  • Fig. 1 Initial MRI at the time of diagnosis and retrospectively traced mass at 6 years ago MRI. A: Brain MRI revealed slightly high signal on T2-axial well-delinated ovoid mass in the 4th ventricle floor. B: The mass (arrow) was retrospectively found on MRI taken after aneurysmal clipping and ventriculo-peritoneal shunt 6 years ago. C: T1-sagittal MRI revealed, iso-signal intensity, and D: fuzzy enhancing mass after gadolinium enhancement.

  • Fig. 2 Serial yearly follow up MRIs from 2013 to 2017 (A–F) reveal continuous growing 4th ventricle tumor on T2 (left of each) and T1 gadolinium enhanced image (right of each). The largest tumor diameter increased from 9 mm to 30 mm in 6 years but she remained asymptomatic up to 6th year.

  • Fig. 3 Comparison of mass size on T1 gadolinium enhanced MR images between (A) the last year of patient being asymptomatic and (B) the 7th year of patient developing intolerable nausea and vomiting at the age of 74 years-old.

  • Fig. 4 Midline suboccipital craniotomy were used for resection of 4th ventricle tumor (A). The tumor was exposed between cerebellar tonsils. It was fragile and colored grey to purple (B). Using telovelar approach, we could easily dissect tumor from the cerebellum and the roof of 4th ventricle. We leaved small seam of tumor (arrows) adhered to dorsal lip of 4th ventricle, and near total resection of the tumor was achieved.

  • Fig. 5 Pathologic feature of ependymoma. A: This celluilar tumor is composed of small round cells. The tumor cells are arranged around blood vessels with intervening anucleate zones, forming perivascular pseudorosettes.(H-E, ×100). B: In close up view, tumor cell processes converge on the blood vessels creating fibrillar zone of pseudorosettes (H-E, ×200). C: True ependymal rosettes having luminal spaces are also noted (H-E, ×100). D: Dot-like perinuclear immunopositivity on EMA stain is characteristic. It indicates intracellular lumen of ependymal tumor cells (EMA, ×100). H-E, hematoxylin and eosin; EMA, epithelial membrane antigen.

  • Fig. 6 Postoperative MRI revealed total excision of enhancing mass with linear enhancement of surgical tract (A). The region demonstrates abnormally diffusion restricted and low apparent diffusion coefficient values explain transient postoperative neurological deficit of the patient (B).


Reference

1. Metellus P, Guyotat J, Chinot O, et al. Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol. 2010; 12:976–984. PMID: 20484442.
Article
2. Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases. Cancer. 1977; 40:907–915. PMID: 890671.
3. Guyotat J, Metellus P, Giorgi R, et al. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien). 2009; 151:947–960. PMID: 19499166.
Article
4. Jung TY, Jung S, Kook H, Baek HJ. Treatment decisions of World Health Organization grade II and III ependymomas in molecular era. J Korean Neurosurg Soc. 2018; 61:312–318. PMID: 29742878.
Article
5. Hayashi T, Inamasu J, Kanai R, Sasaki H, Shinoda J, Hirose Y. Clinical, histological, and genetic features of fourth ventricle ependymoma in the elderly. Neurol Med Chir (Tokyo). 2012; 52:611–616. PMID: 22976148.
Article
6. Ferguson SD, Levine NB, Suki D, et al. The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg. 2018; 128:339–351. PMID: 28409732.
Article
7. Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME. Predictors of survival among older adults with ependymoma. J Neurooncol. 2012; 107:183–189. PMID: 21952907.
Article
8. Jung HW, Yoo H, Paek SH, Choi KS. Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery. 2000; 46:567–574. discussion 574-5. PMID: 10719852.
Article
9. Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006; 27:547–552. PMID: 16791048.
Article
10. Saito T, Oki S, Mikami T, et al. [Supratentorial ectopic ependymoma: a case report]. No Shinkei Geka. 1999; 27:1139–1144. PMID: 10629896.
11. Ehtesham M, Kabos P, Yong WH, Schievink WI, Black KL, Yu JS. Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surg Neurol. 2003; 60:80–82. discussion 83. PMID: 12865022.
Article
12. Sugawara T, Murakami R, Saito R, et al. [Two cases of ependymoma with atypical presentation]. Rinsho Hoshasen. 2003; 48:1218–1221.
13. Araki T, Shimono T, Kuwabara M, et al. [Two cases of ependymoma with atypical presentation]. Rinsho Hoshasen. 2008; 53:1141–1145.
14. Lord H, Ironside J, Summers D, Gregor A, Erridge S, Myles L. Fourth ventricle ependymoma in father and son. Br J Neurosurg. 2008; 22:423–425. PMID: 17952721.
Article
15. Montano N, De Bonis P, Doglietto F, et al. Teaching NeuroImage: hemorrhagic ependymoma in the elderly: a rare cause of headache and gait imbalance. Neurology. 2008; 70:e95. PMID: 18519865.
Article
16. Scheithauer BW, Swearingen B, Whyte ET, Auluck PK, Stemmer-Rachamimov AO. Ependymoma of the sella turcica: a variant of pituicytoma. Hum Pathol. 2009; 40:435–440. PMID: 18992914.
Article
17. Shintaku M, Hashimoto K. Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult. Brain Tumor Pathol. 2012; 29:31–36. PMID: 21833575.
Article
Full Text Links
  • BTRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr